Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
Text
Xcopri® (cenobamate) – New drug approval
November 21, 2019 - The FDA announced the approval of SK Biopharmaceuticals’ Xcopri (cenobamate), for the treatment of partial-onset seizures in adult patients.
